Cancer

Breast Cancer Awareness Month: Why Nabta Health Founder Sophie Smith Is Asking You to #UnthinkThePink

Asieris’ Cevira, the First Non-Vaccine Investigational Product for Cervical HSIL, Has Achieved Its Primary Endpoint

NK:IO Secures £1.2M in Latest Funding Round to Advance Ovarian Cancer Treatment with Cell Therapy

Spotlight: Ovarian Cancer

Innovation in Gynecological Cancer Diagnostics and Care

Nevia Bio Secures $3M in Seed Funding to Advance Machine Learning in Women’s Health Diagnostics

Delphinus Raises $12M for Its 3D Whole Breast Ultrasound Tomography System to Invest in Further Expansion

Ovarian Cancer Treatment: FDA Approves Clinical Trials for Leads Biolabs’ LBL-033

Women’s Health Company Mithra Reports Promising Data for Its CSF-1R Inhibitor in Preclinical Cancer Models

Roche’s HPV Screening Test Receives WHO Prequalification

Novartis’ Kisqali Shows Promising Results in Reducing Breast Cancer Recurrence

Women-led Perci Health Adds £3.4M in Seed Funding for Its Digital Cancer Care Platform

Google Health AI Announces New Women’s Health Partnerships

New Findings from Apple’s Menstrual Health Study Suggest Connection Between PCOS and Endometrial Hyperplasia

New Study by MyOme Suggests Cross-Ancestry Polygenic Risk Score Improves Breast Cancer Prediction

Rosy Founder Dr. Lyndsey Harper: “Using technology to bridge gaps in care is the solution women and their providers have been searching for.”

Qvin’s Menstrual Blood Diagnostic Device Receives FDA Approval in Thailand

Mica AI Medical Raises $3M for Its Breast Cancer Diagnostics Platform

Teal Health Adds $8.8M in Seed Funding to Tackle Cervical Cancer

AOA Dx Reaches Initial Validation of Novel Tumor Gangliosides as Diagnostic Markers for Early Detection of Ovarian Cancer

Delphinus Adds $30M in Series D Funding to Take Its 3D Whole Breast Ultrasound Tomography System to Market

AOA Dx Adds $4.5M in Seed Funding to Develop the Next Generation of Its Ovarian Cancer Detection Technology

Singaporean Breast Cancer Diagnostics AI Startup FathomX Raises $2M in Pre-Series A Funding

PINK!, A Digital Therapeutic for Breast Cancer Patients, Is Now Reimbursed as a Prescription Digital Health Product (DiGA) in Germany